Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 84 (3) , 345-352
- https://doi.org/10.1016/s1081-1206(10)62785-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of severe atopic dermatitis in childhood with cyclosporinBritish Journal of Dermatology, 1996
- Cyclosporine in severe childhood atopic dermatitis: A multicenter studyJournal of the American Academy of Dermatology, 1996
- Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitisJournal of Allergy and Clinical Immunology, 1996
- Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitisArchives of Dermatology, 1996
- Elevated Serum Levels of Soluble Adhesion Molecules ICAM-1 and ELAM-1 in Patients with Severe Atopic Eczema and Influence of UVA1 TreatmentDermatology, 1995
- High dose gammaglobulin treatment for atopic dermatitis.Archives of Disease in Childhood, 1994
- E‐selectin and vascular cell adhesion molecule‐1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitisJournal of Cutaneous Pathology, 1994
- Lesional expression of interferon-γ in atopic eczemaThe Lancet, 1994
- What do members of the National Eczema Society really want?Clinical and Experimental Dermatology, 1993
- Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens.Journal of Clinical Investigation, 1993